153 related articles for article (PubMed ID: 37541813)
1. The association between comorbidities and disease activity in spondyloarthritis - A narrative review.
Bosch P; Zhao SS; Nikiphorou E
Best Pract Res Clin Rheumatol; 2023 Sep; 37(3):101857. PubMed ID: 37541813
[TBL] [Abstract][Full Text] [Related]
2. Role of comorbidities in spondyloarthritis including psoriatic arthritis.
Scriffignano S; Perrotta FM; De Socio A; Lubrano E
Clin Rheumatol; 2019 Jan; 38(1):3-10. PubMed ID: 30338414
[TBL] [Abstract][Full Text] [Related]
3. Comorbidities in spondyloarthritis including psoriatic arthritis.
Moltó A; Dougados M
Best Pract Res Clin Rheumatol; 2018 Jun; 32(3):390-400. PubMed ID: 31171310
[TBL] [Abstract][Full Text] [Related]
4. Comorbidities Associated with Psoriatic Arthritis Compared with Non-psoriatic Spondyloarthritis: A Cross-sectional Study.
Haque N; Lories RJ; de Vlam K
J Rheumatol; 2016 Feb; 43(2):376-82. PubMed ID: 26669922
[TBL] [Abstract][Full Text] [Related]
5. Comorbidity management in spondyloarthritis.
López-Medina C; Molto A
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32892168
[TBL] [Abstract][Full Text] [Related]
6. Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis: results from the ASAS-COMOSPA study.
Stolwijk C; Essers I; van den Bosch F; Dougados M; Etcheto A; van der Heijde D; Landewé R; Molto A; van Tubergen A; Boonen A;
Rheumatology (Oxford); 2020 Jul; 59(7):1632-1639. PubMed ID: 31665462
[TBL] [Abstract][Full Text] [Related]
7. Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.
Iannone F; Salaffi F; Fornaro M; Di Carlo M; Gentileschi S; Cantarini L; Lopalco G
Eur J Clin Invest; 2018 Nov; 48(11):e13013. PubMed ID: 30079593
[TBL] [Abstract][Full Text] [Related]
8. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force.
Smolen JS; Braun J; Dougados M; Emery P; Fitzgerald O; Helliwell P; Kavanaugh A; Kvien TK; Landewé R; Luger T; Mease P; Olivieri I; Reveille J; Ritchlin C; Rudwaleit M; Schoels M; Sieper J; Wit Md; Baraliakos X; Betteridge N; Burgos-Vargas R; Collantes-Estevez E; Deodhar A; Elewaut D; Gossec L; Jongkees M; Maccarone M; Redlich K; van den Bosch F; Wei JC; Winthrop K; van der Heijde D
Ann Rheum Dis; 2014 Jan; 73(1):6-16. PubMed ID: 23749611
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study.
Stouten V; Pazmino S; Verschueren P; Mamouris P; Westhovens R; de Vlam K; Bertrand D; Van der Elst K; Vaes B; De Cock D
RMD Open; 2021 Jun; 7(2):. PubMed ID: 34158353
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study.
Moltó A; Etcheto A; van der Heijde D; Landewé R; van den Bosch F; Bautista Molano W; Burgos-Vargas R; Cheung PP; Collantes-Estevez E; Deodhar A; El-Zorkany B; Erdes S; Gu J; Hajjaj-Hassouni N; Kiltz U; Kim TH; Kishimoto M; Luo SF; Machado PM; Maksymowych WP; Maldonado-Cocco J; Marzo-Ortega H; Montecucco CM; Ozgoçmen S; van Gaalen F; Dougados M
Ann Rheum Dis; 2016 Jun; 75(6):1016-23. PubMed ID: 26489703
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis.
Citera G; Bautista-Molano W; Peláez-Ballestas I; Azevedo VF; Perich RA; Méndez-Rodríguez JA; Cutri MS; Borlenghi CE
Adv Rheumatol; 2021 Jan; 61(1):2. PubMed ID: 33419481
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation.
Rondags A; Arends S; Wink FR; Horváth B; Spoorenberg A
Semin Arthritis Rheum; 2019 Feb; 48(4):611-617. PubMed ID: 29751976
[TBL] [Abstract][Full Text] [Related]
13. Development and feasibility of 4 checklists for the evaluation of comorbidity in patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis: GECOAI Project.
Castañeda S; González C; Villaverde V; Lajas Petisco C; Castro MC; Jirout F; Obaya JC; Hermosa JC; Suárez C; García S; Rodero M; León L; López Esteban A; Gobbo M; Alcaide L; Torre-Alonso JC
Reumatol Clin (Engl Ed); 2022 Feb; 18(2):114-123. PubMed ID: 35153034
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease in spondyloarthritis: a narrative review of risk factors and the effect of treatments.
Sen R; Caplan L; Danila MI
Curr Opin Rheumatol; 2024 Mar; 36(2):95-107. PubMed ID: 38126207
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of comorbidities and evaluation of screening in Chinese patients with spondyloarthritis.
Jiang Y; Zhang P; Tu L; Lv Q; Qi J; Lin Z; Liao Z; Cao S; Gu J
Clin Rheumatol; 2018 Feb; 37(2):423-428. PubMed ID: 29204757
[TBL] [Abstract][Full Text] [Related]
16. Psoriatic arthritis and spondyloarthritis assessment and management update.
Mease P
Curr Opin Rheumatol; 2013 May; 25(3):287-96. PubMed ID: 23492739
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Comorbidities and Risk Factors for Comorbidities in Patients with Spondyloarthritis in Latin America: A Comparative Study with the General Population and Data from the ASAS-COMOSPA Study.
Bautista-Molano W; Landewé R; Burgos-Vargas R; Maldonado-Cocco J; Moltó A; van den Bosch F; Valle-Oñate R; Dougados M; van der Heijde D
J Rheumatol; 2018 Feb; 45(2):206-212. PubMed ID: 29247152
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a special concept of physical therapy in spondyloarthritis: German multimodal rheumatologic complex treatment for spondyloarthritis.
Klemm P; Hudowenz O; Asendorf T; Dischereit G; Müller-Ladner U; Lange U; Tarner IH
Clin Rheumatol; 2020 May; 39(5):1513-1520. PubMed ID: 31916106
[TBL] [Abstract][Full Text] [Related]
19. Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis.
Lauper K; Courvoisier DS; Chevallier P; Finckh A; Gabay C
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1756-1763. PubMed ID: 29609199
[TBL] [Abstract][Full Text] [Related]
20. Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis.
Frede N; Rieger E; Lorenzetti R; Nieters A; Venhoff AC; Hentze C; von Deimling M; Bartholomä N; Thiel J; Voll RE; Venhoff N
Front Immunol; 2022; 13():1040725. PubMed ID: 36389682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
